Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
7 studies found for:    4272516 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed EMD 128130 for the Treatment of Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: EMD 128130;   Drug: IV Levodopa
2 Completed Study of LY300164 for the Treatment of Parkinson's Disease
Conditions: Dyskinesias;   Parkinson Disease
Intervention: Drug: LY300164
3 Completed Riluzole to Treat Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: IV Levodopa
4 Completed Prognostic Value of FP-CIT-SPECT in Parkinson´s Disease
Condition: Parkinson´s Disease
Intervention:
5 Completed Levetiracetam Treatment of L-Dopa Induced Dyskinesias
Conditions: Dyskinesias;   Parkinson Disease
Intervention: Drug: Intravenous Levodopa
6 Completed Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: NS2330;   Drug: Levodopa and Domperidone
7 Completed KW-6002 to Treat Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: KW-6002;   Drug: IV Levodopa

Indicates status has not been verified in more than two years